Dengue Seroprevalence Study in Blood Donors in the French West Indies

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT01104740

Acronym

DengSeroprevAn

Enrollment

817

Registered

2010-04-15

Start date

2011-05-31

Completion date

2012-05-31

Last updated

2021-08-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood Donors, Dengue

Brief summary

Dengue is an infectious disease most prevalent in the world. This disease is endemic in the Caribbean, with an increase in seasonal rains. Several outbreaks have been observed in recent years, in 2001, 2005 and 2007, during which further particularly virulent serotypes have emerged. The clinical expression of dengue fever is variable, ranging from no symptoms to a classical form with fever, and even of severe or lethal bleeding. With the possible existence of silent forms of the disease, there are no data identifying the current level of protection of the population in Martinique / Guadeloupe.

Detailed description

1. Principal objective: To estimate the prevalence of the specific antibodies of the dengue (IgG) in blood donors in the French West Indies. 2. Secondary objective: To specify the serotypic specificity of the anti-dengue antibodies detected during the study.

Interventions

OTHERBiological sample collection

Blood (serum) sample collection

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Eligible for blood donation following the French legislation, * Resident in Martinique /Guadeloupe for at least one year * Consent signed

Exclusion criteria

* Not Eligible for blood donation following the French legislation, * Not Resident in Martinique / Guadeloupe for at least one year * Consent not signed

Design outcomes

Primary

Measure	Time frame
Presence or not of dengue virus-specific immunoglobulin G antibodies	1 day

Secondary

Measure	Time frame	Description
Characterization of dengue virus serotype-specific IgG	1 day	Characterization of dengue virus serotype-psecific IgG whendengue virus serotype-specific immunoglobulin G antibodies Test is positive

Countries

Guadeloupe, Martinique

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026